Acotec Scientific Holdings Ltd

Acotec Scientific Holdings Limited is an interventional medical device company offering vascular interventional treatment products in Mainland China and internationally. Its products include the AcoArt Orchid & Dhalia paclitaxel DCB for preventing stenosis or occlusion in the superficial femoral and popliteal arteries in lower extremity artery disease, and the AcoArt Tulip & Litos paclitaxel-coated DCB for preventing stenosis or occlusion in below-the-knee arteries in chronic limb-threatening ischemia. It also offers vascular surgery devices, cardiology devices, nephrology devices, and neurology devices, and trades in procedural medical devices. Founded in 2011 and headquartered in Beijing, China, the company operates as a subsidiary of Boston Scientific Group plc.